GILD

Gilead Sciences, Inc. News Headlines

$103.06
*  
0.27
0.26%
Get GILD Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha


Notable ETF Inflow Detected - XLV, MRK, GILD, UNH
11/11/2014 10:57:48 AM - BNK Invest


Are Expensive Biotech Drugs Bad For Business?
11/11/2014 10:45:00 AM - Seeking Alpha


Stock Market News for November 11, 2014 - Market News
11/11/2014 10:10:00 AM - Zacks.com


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much
11/11/2014 8:52:30 AM - Motley Fool


Cramer's Mad Money - Disney Is A Sleep At Night Stock (11/10/14)
11/11/2014 4:09:00 AM - Seeking Alpha


Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
11/10/2014 4:45:00 PM - Zacks.com


Stocks Quietly Grind Higher, But Stifled By Lack of Fresh Catalysts
11/10/2014 12:42:26 PM - MT Newswires


Why Gilead Sciences Stock Is Still A Buy
11/10/2014 11:10:00 AM - Seeking Alpha


Pre-Market Most Active for Nov 10, 2014 : BABA, ALU, MTU, GILD, GPRO, PBR, QQQ, NVO, ACHN, TVIX, NMR, AAPL
11/10/2014 8:39:57 AM - NASDAQ.com News


3 Drugs That Make Gilead Sciences' Harvoni Look Cheap
11/10/2014 7:31:03 AM - Motley Fool


5 Prescription Drugs Selling Like Hot Cakes
11/9/2014 10:01:03 AM - Motley Fool


3 Biotech Stocks to Watch in November
11/8/2014 11:03:17 AM - Motley Fool


Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
11/7/2014 6:50:00 PM - Zacks.com


Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig
11/7/2014 1:42:17 PM - Motley Fool


Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns
11/7/2014 9:16:00 AM - Seeking Alpha


Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 10, 2014
11/7/2014 9:00:03 AM - NASDAQ.com News


Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
11/7/2014 8:45:02 AM - Motley Fool


5 Things AbbVie Inc.'s Management Wants You to Know
11/6/2014 12:38:03 PM - Motley Fool


Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October
11/6/2014 9:40:03 AM - Motley Fool


Why The Next Correction Could Come In The First Quarter
11/6/2014 9:17:00 AM - Seeking Alpha


ETF Outlook: First Trust Amex Biotech Index Fund ETF (FBT)
11/6/2014 8:32:36 AM - Marc Chaikin


Gilead Sciences - What Convinced Me To Become Bullish
11/5/2014 12:41:00 PM - Seeking Alpha


Gilead: Stay The Course
11/5/2014 11:51:00 AM - Seeking Alpha